119 related articles for article (PubMed ID: 24268420)
21. Identification of clinical risk factors of atrial fibrillation in congestive heart failure.
Targoński R; Sadowski J; Romaszko J; Cichowski L
Cardiol J; 2013; 20(4):364-9. PubMed ID: 23913454
[TBL] [Abstract][Full Text] [Related]
22. [Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion].
Zarauza J; Rodríguez Lera MJ; Fariñas Alvarez C; Hernando JP; Ceballos B; Gutiérrez B; Pérez J; Cuesta JM
Rev Esp Cardiol; 2006 Feb; 59(2):125-9. PubMed ID: 16540033
[TBL] [Abstract][Full Text] [Related]
23. Relation of urotensin II levels to lone atrial fibrillation.
Zhang L; Ding R; Zhen Y; Wu ZG
Am J Cardiol; 2009 Dec; 104(12):1704-7. PubMed ID: 19962480
[TBL] [Abstract][Full Text] [Related]
24. High concentrations of B-type natriuretic peptide and left ventricular diastolic dysfunction in patients with paroxysmal/persistent atrial fibrillation as possible markers of conversion into permanent form of arrhythmia: 1-year prospective evaluation.
Dabrowski R; Borowiec A; Janas J; Firek B; Kowalik I; Smolis-Bak E; Luczak D; Sosnowski C; Kazimierska B; Szwed H
Kardiol Pol; 2010 Aug; 68(8):893-900. PubMed ID: 20730719
[TBL] [Abstract][Full Text] [Related]
25. The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation.
Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Kolyvaki SG; Lyrarakis GM; Chlouverakis GI; Vardas PE
Heart; 2008 Feb; 94(2):200-4. PubMed ID: 17575330
[TBL] [Abstract][Full Text] [Related]
26. Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence.
Okumura Y; Watanabe I; Nakai T; Ohkubo K; Kofune T; Kofune M; Nagashima K; Mano H; Sonoda K; Kasamaki Y; Hirayama A
J Cardiovasc Electrophysiol; 2011 Sep; 22(9):987-93. PubMed ID: 21489023
[TBL] [Abstract][Full Text] [Related]
27. Source of inflammatory markers in patients with atrial fibrillation.
Liuba I; Ahlmroth H; Jonasson L; Englund A; Jönsson A; Säfström K; Walfridsson H
Europace; 2008 Jul; 10(7):848-53. PubMed ID: 18523031
[TBL] [Abstract][Full Text] [Related]
28. C-reactive protein and atrial fibrillation: "evidence for the presence of inflammation in the perpetuation of the arrhythmia".
Acevedo M; Corbalán R; Braun S; Pereira J; Navarrete C; Gonzalez I
Int J Cardiol; 2006 Apr; 108(3):326-31. PubMed ID: 15985301
[TBL] [Abstract][Full Text] [Related]
29. The association of plasma oxidative status and inflammation with the development of atrial fibrillation in patients presenting with ST elevation myocardial infarction.
Bas HA; Aksoy F; Icli A; Varol E; Dogan A; Erdogan D; Ersoy I; Arslan A; Ari H; Bas N; Sutcu R; Ozaydin M
Scand J Clin Lab Invest; 2017 Apr; 77(2):77-82. PubMed ID: 27905214
[TBL] [Abstract][Full Text] [Related]
30. Time course of inflammation, myocardial injury, and prothrombotic response after radiofrequency catheter ablation for atrial fibrillation.
Lim HS; Schultz C; Dang J; Alasady M; Lau DH; Brooks AG; Wong CX; Roberts-Thomson KC; Young GD; Worthley MI; Sanders P; Willoughby SR
Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):83-9. PubMed ID: 24446024
[TBL] [Abstract][Full Text] [Related]
31. [Association of plasma fibronectin level with left atrial electrical and structural remodelling in lone paroxysmal atrial fibrillation: a cross-sectional study].
Canpolat U; Oto A; Yorgun H; Sunman H; Şahiner L; Kaya EB; Özer N; Aytemir K
Turk Kardiyol Dern Ars; 2015 Apr; 43(3):259-68. PubMed ID: 25905997
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of time course and predicting factors of progression of paroxysmal or persistent atrial fibrillation to permanent atrial fibrillation.
DE Sisti A; Leclercq JF; Halimi F; Fiorello P; Bertrand C; Attuel P
Pacing Clin Electrophysiol; 2014 Mar; 37(3):345-55. PubMed ID: 24236932
[TBL] [Abstract][Full Text] [Related]
33. Preoperative C-reactive protein and atrial fibrillation after off-pump coronary bypass surgery.
Kinoshita T; Asai T; Takashima N; Hosoba S; Suzuki T; Kambara A; Matsubayashi K
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1298-303. PubMed ID: 21514836
[TBL] [Abstract][Full Text] [Related]
34. C-reactive protein but not atrial dysfunction predicts recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
Lombardi F; Tundo F; Belletti S; Mantero A; Melzi D'eril GV
J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):581-8. PubMed ID: 18475126
[TBL] [Abstract][Full Text] [Related]
35. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation.
Mohanty S; Mohanty P; Di Biase L; Bai R; Pump A; Santangeli P; Burkhardt D; Gallinghouse JG; Horton R; Sanchez JE; Bailey S; Zagrodzky J; Natale A
J Am Coll Cardiol; 2012 Apr; 59(14):1295-301. PubMed ID: 22464257
[TBL] [Abstract][Full Text] [Related]
36. Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients.
Kaireviciute D; Blann AD; Balakrishnan B; Lane DA; Patel JV; Uzdavinys G; Norkunas G; Kalinauskas G; Sirvydis V; Aidietis A; Lip GY
Thromb Haemost; 2010 Jul; 104(1):122-7. PubMed ID: 20458440
[TBL] [Abstract][Full Text] [Related]
37. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.
Wozakowska-Kapłon B; Opolski G
Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231
[TBL] [Abstract][Full Text] [Related]
38. High-sensitivity troponin T as a biomarker for the development of atrial fibrillation after cardiac surgery.
Hernández-Romero D; Vílchez JA; Lahoz Á; Romero-Aniorte AI; Orenes-Piñero E; Caballero L; Jara-Rubio R; Arribas JM; García-Alberola A; Valdés M; Lip GY; Marín F
Eur J Cardiothorac Surg; 2014 Apr; 45(4):733-8. PubMed ID: 24163361
[TBL] [Abstract][Full Text] [Related]
39. Self-reported sleep quality of patients with atrial fibrillation and the effects of cardioversion on sleep quality.
Kayrak M; Gul EE; Aribas A; Akilli H; Alibasiç H; Abdulhalikov T; Yildirim O; Yazici M; Ozdemir K
Pacing Clin Electrophysiol; 2013 Jul; 36(7):823-9. PubMed ID: 23437796
[TBL] [Abstract][Full Text] [Related]
40. The predictive value of C-reactive protein on recurrence of atrial fibrillation after cardioversion with or without treatment with atorvastatin.
Höglund N; Andersson J; Almroth H; Tornvall P; Englund A; Rosenqvist M; Jensen SM; Boman K
Int J Cardiol; 2013 Sep; 167(5):2088-91. PubMed ID: 22704860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
